Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.
Al-Obaidi N, Mohan S, Liang S, Zhao Z, Nayak BK, Li B, Sriramarao P, Habib SL.
Al-Obaidi N, et al. Among authors: li b.
FASEB J. 2019 Jan;33(1):373-387. doi: 10.1096/fj.201800555RR. Epub 2018 Jul 5.
FASEB J. 2019.
PMID: 29975570
Free PMC article.
Inhibition of Gal-1 by OTX-008 blocks activation of Akt and prevents accumulation of Gal-1, suggesting a novel role of Gal-1 inhibitor as a possible therapeutic target to treat renal fibrosis in diabetes.-Al-Obaidi, N., Mohan, S., Liang, S., Zhao, Z., Nayak, B. K., Li …
Inhibition of Gal-1 by OTX-008 blocks activation of Akt and prevents accumulation of Gal-1, suggesting a novel role of Gal-1 inhibitor as a …